introduct
sinc
sever
case
emerg
human
adenoviru
type
immunocompet
adult
report
sporad
china
clinic
featur
outcom
critic
ill
patient
sever
acut
respiratori
distress
syndrom
ard
caus
requir
invas
mechan
ventil
imv
andor
extracorpor
membran
oxygen
ecmo
lack
method
conduct
prospect
singlecent
observ
studi
pneumonia
ard
immunocompet
adult
admit
respiratori
icu
prospect
collect
analyz
clinic
laboratori
radiolog
characterist
sequenti
test
viral
load
respiratori
tract
blood
treatment
outcom
result
total
five
consecut
patient
sever
ard
confirm
infect
includ
five
patient
immunocompet
young
men
median
age
year
mean
time
onset
dyspnea
day
arteri
blood
ga
analysi
icu
admiss
reveal
profound
hypoxia
mean
partial
oxygen
pressurefract
inspir
oxygen
mean
durat
onset
singlelob
consolid
shown
chest
xray
cxr
first
posit
cxr
bilater
multilobar
lung
infiltr
day
day
respect
viral
load
higher
copi
three
patient
one
patient
neg
patient
surviv
mean
durat
noninvas
posit
pressur
ventil
nppv
failur
imv
failur
hour
day
respect
four
patient
receiv
venoven
ecmo
four
five
patient
die
despit
receiv
appropri
respiratori
support
conclus
may
caus
sever
ard
immunocompet
young
men
persist
high
fever
dyspnea
rapid
progress
respiratori
failur
within
week
togeth
bilater
consolid
infiltr
frequent
clinic
manifest
sever
ard
viral
load
monitor
may
help
predict
diseas
sever
outcom
nppv
imv
failur
rate
high
ecmo
may
still
respiratori
support
therapi
choic
human
adenovirus
hadv
notori
pathogen
peopl
compromis
immun
function
frequent
caus
outbreak
acut
respiratori
diseas
among
young
children
lifethreaten
adenovir
pneumonia
previous
document
among
militari
traine
patient
aid
transplant
recipi
human
adenoviru
type
emerg
highli
virul
pathogen
acut
fatal
adenovir
pneumonia
among
immunocompet
adult
china
gain
increas
attent
newli
identifi
emerg
acut
respiratori
diseas
pathogen
caus
two
recent
outbreak
china
singapor
pathogen
appar
reemerg
beij
china
caus
sever
case
sever
communityacquir
pneumonia
pathogen
fulli
character
wholegenom
sequenc
compar
studi
show
abil
hadv
caus
sever
diseas
may
relat
serotyp
hadv
sever
adenovir
pneumonia
induc
report
close
relat
sever
case
compar
serotyp
current
knowledg
sever
acut
respiratori
distress
syndrom
ard
requir
invas
mechan
ventil
andor
extracorpor
membran
oxygen
ecmo
support
immunocompet
adult
deriv
singl
case
report
rel
small
singlecent
seri
result
littl
inform
avail
pneumonia
complic
sever
ard
frequenc
expect
increas
come
year
describ
clinic
featur
outcom
five
prospect
case
pneumonia
complic
sever
ard
immunocompet
adult
icu
begin
may
random
trial
noninvas
posit
pressur
ventil
nppv
ard
patient
carri
center
clinicaltrialsgov
id
may
april
adult
patient
ard
caus
pneumonia
admit
respiratori
icu
beij
chaoyang
hospit
prospect
enrol
sever
ard
diagnos
accord
berlin
definit
develop
within
week
known
clinic
insult
new
worsen
respiratori
symptom
bilater
opac
fulli
explain
effus
lobar
andor
lung
collaps
nodul
respiratori
failur
fulli
explain
cardiac
failur
fluid
overload
partial
oxygen
pressur
fraction
inspir
oxygen
pao
fio
mmhg
posit
endexpiratori
pressur
peep
cmh
chest
radiograph
three
four
quadrant
opac
patient
infect
sever
ard
fail
convent
nppv
invas
mechan
ventil
imv
includ
analysi
studi
approv
institut
review
board
beij
chaoyang
hospit
data
analyz
anonym
patient
gave
written
inform
consent
data
use
research
public
clinic
inform
collect
investig
standard
data
form
includ
follow
demograph
characterist
age
sex
comorbid
clinic
symptom
fever
cough
sputum
dyspnea
chest
pain
rash
nausea
vomit
abdomin
pain
diarrhea
headach
sign
bodi
temperatur
heart
rate
respiratori
frequenc
blood
pressur
crackl
lung
laboratori
test
wholeblood
cell
count
blood
chemistri
microbiolog
find
imag
lung
chest
xray
cxr
comput
tomographi
concomit
medic
respiratori
support
complic
outcom
also
record
patient
specimen
includ
sputum
whole
blood
serum
sampl
collect
upon
admiss
hospit
microbiolog
test
perform
depart
infecti
diseas
clinic
microbiolog
center
detect
method
use
describ
previou
report
common
virus
caus
respiratori
ill
screen
use
kit
differ
viral
assay
serum
sampl
use
mycoplasma
pneumonia
chlamydia
pneumonia
legionella
pneumophila
antibodi
patient
infect
confirm
rtpcr
assay
partial
sequenc
hexon
gene
analyz
type
phylogeni
strain
adenovir
load
also
perform
respiratori
specimen
blood
multiplex
rtpcr
assay
viral
pneumonia
diagnos
base
presenc
hadv
detect
sputum
throat
swab
sampl
molecular
method
continu
variabl
summar
mean
standard
deviat
sd
median
interquartil
rang
studi
period
total
eight
patient
diagnos
hadv
infect
respiratori
failur
admit
icu
seven
receiv
diagnosi
ard
five
consecut
patient
sever
ard
confirm
infect
admit
icu
april
juli
includ
analysi
two
patient
mild
ard
infect
type
hadv
five
patient
immunocompet
young
men
median
age
year
rang
year
patient
share
b
blood
type
came
citi
baod
citi
hebei
provinc
northern
china
patient
exposur
farm
anim
corn
hay
patient
tuberculosi
pleuriti
receiv
antituberculosi
therapi
icu
admiss
blood
test
includ
tspot
tuberculosi
assay
oxford
immunotec
marlborough
usa
antibodi
mycobacterium
tuberculosi
neg
flulik
symptom
fever
cough
littl
sputum
commonli
observ
onset
ill
patient
present
high
fever
mean
bodi
temperatur
rang
persist
day
rang
day
product
cough
observ
two
patient
dull
substern
chest
pain
rash
also
observ
two
patient
patient
dyspnea
mean
time
onset
dyspnea
day
rang
day
onset
dyspnea
patient
usual
progress
respiratori
failur
hypoxemia
mean
time
onset
icu
admiss
day
rang
day
tabl
patient
tachypnea
admit
icu
mean
rate
breath
per
minut
rang
arteri
blood
ga
analysi
icu
admiss
reveal
profound
hypoxia
mean
pao
fio
rang
white
blood
cell
count
low
normal
rang
patient
elev
serum
aspart
aminotransferas
ast
lactat
dehydrogenas
ldh
hydroxybutyr
dehydrogenas
hbdh
tabl
admiss
patient
level
immunoglobulin
serum
immunoglobulin
g
compon
normal
rang
four
patient
lower
normal
tcell
subset
count
tabl
cxr
reveal
multipl
bilater
lobar
segment
consolid
lung
five
patient
radiograph
lesion
progress
rapidli
icu
admiss
figur
three
patient
examin
highresolut
comput
tomographi
hrct
unilater
bilater
consolid
infiltr
found
hrct
scan
three
patient
consolid
within
singl
lobe
sever
lobe
clear
border
air
bronchogram
common
find
hrct
scan
nodul
patch
pleural
effus
abscess
caviti
also
seen
visual
hrct
figur
mean
durat
onset
singlelob
consolid
cxr
day
rang
day
mean
durat
first
posit
cxr
bilater
multilobar
lung
infiltr
day
rang
day
patient
viremia
four
five
patient
first
detect
endotrach
aspir
eta
sampl
time
initi
eta
sampl
collect
adenovirus
posit
result
nucleic
acid
blood
day
tabl
viru
dna
copi
eta
determin
patient
icu
stay
viral
load
higher
copi
three
patient
one
patient
viral
load
becam
neg
patient
surviv
four
patient
surviv
dna
copi
decreas
even
antivir
therapi
figur
oxygen
maintain
convent
nppv
imv
support
patient
mean
durat
nppv
failur
hour
rang
hour
mean
time
imv
failur
day
rang
day
tabl
four
patient
receiv
venoven
ecmo
maintain
oxygen
satur
one
patient
refus
ecmo
support
receiv
highfrequ
oscillatori
ventil
instead
tabl
give
oxygen
data
patient
venoven
ecmo
support
patient
receiv
antivir
therapi
includ
acyclovir
mgkg
everi
hour
intraven
drip
ganciclovir
mgkg
everi
hour
intraven
drip
ribavirin
mg
twice
daili
intraven
drip
consid
bacteri
coinfect
may
combin
sever
viral
infect
broadspectrum
intraven
antibiot
given
patient
test
bacteri
pathogen
neg
one
patient
tabl
four
five
patient
die
among
four
patient
receiv
venoven
ecmo
one
patient
surviv
four
patient
die
due
ard
aspergillu
fumigatu
coinfect
septic
shock
catheterrel
bloodstream
infect
due
acinetobact
baumannii
respect
best
knowledg
first
cohort
observ
studi
clinic
characterist
patient
sever
ard
caus
emerg
infect
also
first
evalu
viral
load
test
monitor
reaction
therapi
predict
patient
outcom
follow
main
find
studi
may
caus
sever
ard
immunocompet
young
men
blood
type
b
patient
citi
hebei
provinc
northern
china
persist
high
fever
dyspnea
rapid
progress
respiratori
failur
within
week
togeth
bilater
consolid
infiltr
time
frequent
clinic
manifest
sever
ard
viral
load
monitor
may
help
predict
diseas
sever
patient
outcom
nppv
imv
failur
rate
high
ecmo
may
last
support
method
group
patient
sever
ard
high
mortal
rate
despit
appropri
respiratori
support
sporad
sever
adenovir
infect
healthi
adult
histor
describ
serotyp
serotyp
recent
serotyp
gener
popul
militari
traine
first
complet
character
shaanxi
china
reemerg
hebei
provinc
close
beij
caus
sever
case
acut
respiratori
diseas
presum
recombin
form
speci
due
share
hexon
gene
chassi
result
studi
show
emerg
pathogen
among
immunocompet
adult
may
caus
sever
ard
preval
sever
fatal
adenovir
pneumonia
induc
studi
somewhat
similar
describ
cao
colleagu
case
report
studi
citi
baod
hebei
provinc
northern
china
occur
april
juli
partli
overlap
follow
influenza
epidem
patient
sever
diseas
also
came
region
treat
similar
time
period
suggest
may
import
viral
pathogen
deriv
region
studi
result
suggest
follow
may
clinic
featur
ard
caus
persist
high
fever
rapid
progress
dyspnea
need
mechan
ventil
support
elev
ast
level
rapid
progress
unilater
infiltr
bilater
consolid
clinic
featur
highli
similar
ard
caus
type
hadv
describ
previou
report
recent
studi
shown
immun
system
play
crucial
role
clearanc
hadv
viremia
surviv
host
chen
et
al
report
acut
phase
infect
patient
sever
diseas
may
high
level
dendrit
cell
cell
studi
patient
recov
sever
infect
higher
tcell
count
three
five
patient
rel
low
tcell
count
admit
result
suggest
three
patient
may
rel
immunocompromis
lower
tcell
count
may
risk
factor
infect
young
adult
dna
previous
report
patient
sever
infect
studi
dna
detect
monitor
patient
sever
ard
initi
trend
viral
load
present
dna
copi
respiratori
tract
sampl
blood
may
suggest
sever
infect
may
predict
reaction
therapi
patient
outcom
use
mechan
ventil
ecmo
patient
ard
caus
detail
previou
studi
cohort
found
sever
infect
could
caus
rapid
progress
respiratori
failur
high
failur
rate
nppv
imv
failur
rate
may
result
larg
area
consolid
induc
sever
shunt
lung
may
lead
lack
respons
posit
pressur
ventil
patient
sever
ard
ecmo
consid
better
choic
oxygen
studi
limit
observ
studi
comparison
group
differ
sever
modest
infect
could
clarifi
term
immun
statu
clinic
featur
radiolog
find
viral
load
treatment
effect
respiratori
support
antivir
therapi
sequenti
dynam
analysi
need
determin
relationship
viremia
treatment
respons
